Freeline Therapeutics (FRLN) Short Interest Ratio & Short Volume → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free FRLN Stock Alerts $6.48 0.00 (0.00%) (As of 02/20/2024) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Freeline Therapeutics Short Interest DataCurrent Short Volume23,900 sharesPrevious Short Volume28,300 sharesChange Vs. Previous Month-15.55%Dollar Volume Sold Short$153,916.00Short Interest Ratio / Days to Cover0.6Last Record DateJanuary 31, 2024Outstanding Shares4,340,000 sharesFloat Size4,140,000 sharesShort Percent of Float0.58%Today's Trading Volume5,600 sharesAverage Trading Volume12,055 sharesToday's Volume Vs. Average46% Short Selling Freeline Therapeutics ? Sign up to receive the latest short interest report for Freeline Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFRLN Short Interest Over TimeFRLN Days to Cover Over TimeFRLN Percentage of Float Shorted Over Time Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. Freeline Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202423,900 shares $153,916.00 -15.6%0.6%0.6 $6.44 1/15/202428,300 shares $180,837.00 -41.0%0.7%0.6 $6.39 12/31/202348,000 shares $305,760.00 -6.6%1.2%0.7 $6.37 12/15/202351,400 shares $332,044.00 -35.4%1.2%0.2 $6.46 11/30/202379,500 shares $501,645.00 -21.8%1.9%0.4 $6.31 11/15/2023101,700 shares $492,228.00 -28.5%2.5%0.5 $4.84 Get the Latest News and Ratings for FRLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Freeline Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/2023142,300 shares $712,923.00 -46.8%3.4%0.7 $5.01 10/15/2023267,500 shares $971,025.00 +164.9%6.5%1.3 $3.63 9/30/2023101,000 shares $434,300.00 -2.2%2.4%0.2 $4.30 9/15/2023103,300 shares $387,375.00 -2.5%2.5%0.3 $3.75 8/31/2023105,900 shares $379,122.00 -17.1%2.6%0.3 $3.58 8/15/2023127,800 shares $493,308.00 +22.3%3.1%0.3 $3.86 7/31/2023104,500 shares $379,335.00 -69.7%2.5%0.2 $3.63 7/15/2023345,200 shares $1.94 million +1,164.5%8.4%0.8 $5.63 6/30/202327,300 shares $70,434.00 -50.7%0.7%0.1 $2.58 6/15/202355,400 shares $148,472.00 +93.7%1.3%0.5 $2.68 5/31/202328,600 shares $71,786.00 +271.4%0.7%0.3 $2.51 5/15/20237,700 shares $25,641.00 No Change0.2%0.1 $3.33 10/31/2022147,500 shares $107,674.85 +7.8%N/A4.6 $0.73 10/15/2022136,800 shares $90,288.00 -2.5%N/A3.4 $0.66 9/30/2022140,300 shares $98,210.00 -10.2%N/A2.2 $0.70 9/15/2022156,200 shares $133,051.16 -3.4%N/A2 $0.85 8/31/2022161,700 shares $137,364.15 -1.6%N/A2 $0.85 8/15/2022164,300 shares $161,014.00 -27.9%N/A2 $0.98 7/31/2022227,800 shares $202,742.00 +11.4%N/A2.7 $0.89 7/15/2022204,500 shares $156,912.85 -3.4%N/A2.2 $0.77 6/30/2022211,700 shares $184,179.00 -7.8%N/A1.6 $0.87 6/15/2022229,500 shares $189,314.55 -15.1%N/A1.2 $0.82 5/31/2022270,300 shares $208,103.97 +11.8%N/A1.4 $0.77 5/15/2022241,700 shares $181,275.00 -18.3%1.0%1.2 $0.75 4/30/2022295,700 shares $266,159.57 +8.5%2.5%1.4 $0.90 4/15/2022272,600 shares $278,052.00 -20.9%2.3%1.1 $1.02 3/31/2022344,400 shares $385,728.00 +41.4%N/A1.1 $1.12 3/15/2022243,500 shares $227,185.50 +2.2%0.7%0.3 $0.93 2/28/2022238,200 shares $252,492.00 +3.2%0.7%0.3 $1.06 2/15/2022230,800 shares $281,576.00 -7.5%0.7%0.3 $1.22 1/31/2022249,600 shares $309,504.00 -20.3%0.8%0.3 $1.24 1/15/2022313,300 shares $460,551.00 +249.7%N/A0.3 $1.47 12/31/202189,600 shares $177,408.00 +93.1%0.3%0.1 $1.98 12/15/202146,400 shares $100,688.00 +16.3%0.1%0.5 $2.17Make This $3 Trade the Instant the Opening Bell Rings (Ad)Since the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…See Why This $3.00 Stock Could Hit $15.00 FRLN Short Interest - Frequently Asked Questions What is Freeline Therapeutics' current short interest? Short interest is the volume of Freeline Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 23,900 shares of FRLN short. 0.58% of Freeline Therapeutics' shares are currently sold short. Learn More on Freeline Therapeutics' current short interest. What is a good short interest ratio for Freeline Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FRLN shares currently have a short interest ratio of 1.0. Learn More on Freeline Therapeutics's short interest ratio. What is a good short interest percentage for Freeline Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of Freeline Therapeutics' floating shares are currently sold short. Is Freeline Therapeutics' short interest increasing or decreasing? Freeline Therapeutics saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 23,900 shares, a drop of 15.5% from the previous total of 28,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Freeline Therapeutics' float size? Freeline Therapeutics currently has issued a total of 4,340,000 shares. Some of Freeline Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Freeline Therapeutics currently has a public float of 4,140,000 shares. How does Freeline Therapeutics' short interest compare to its competitors? 0.58% of Freeline Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Freeline Therapeutics: Gamida Cell Ltd. (9.45%), Evaxion Biotech A/S (0.68%), Ocuphire Pharma, Inc. (6.81%), Cardio Diagnostics Holdings, Inc. (2.96%), Agape ATP Co. (0.10%), MEI Pharma, Inc. (0.20%), Movano Inc. (0.16%), eFFECTOR Therapeutics, Inc. (10.49%), Orgenesis Inc. (0.71%), Surrozen, Inc. (0.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Freeline Therapeutics stock? Short selling FRLN is an investing strategy that aims to generate trading profit from Freeline Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Freeline Therapeutics? A short squeeze for Freeline Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FRLN, which in turn drives the price of the stock up even further. How often is Freeline Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FRLN, twice per month. The most recent reporting period available is January, 31 2024. More Short Interest Resources from MarketBeat Related Companies: GMDA Short Interest Data EVAX Short Interest Data OCUP Short Interest Data CDIO Short Interest Data ATPC Short Interest Data MEIP Short Interest Data MOVE Short Interest Data EFTR Short Interest Data ORGS Short Interest Data SRZN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FRLN) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Gates Bets on $15 Trillion BonanzaWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company